Joel E Waymire, MD Pediatrics Medicare: Not Enrolled in Medicare Practice Location: 974 73rd St, Suite 30, Windsor Heights, IA 50312 Phone: 515-224-4993 Fax: 515-224-1505 |
Sayeed B Hussain, MD Pediatrics Medicare: Not Enrolled in Medicare Practice Location: 974 73rd St, Suite 33, Windsor Heights, IA 50312 Phone: 515-223-4146 Fax: 515-223-1172 |
Rhonda J Enserro, MD Pediatrics Medicare: Medicare Enrolled Practice Location: 974 73rd St, Suite 30, Windsor Heights, IA 50312 Phone: 515-224-4993 Fax: 515-224-1505 |
Shoab A Sayeed, DO Pediatrics Medicare: Medicare Enrolled Practice Location: 974 73rd St, Suite 33, Windsor Heights, IA 50312 Phone: 515-223-4146 Fax: 515-223-1172 |
Rachelle L Gammon, DO Pediatrics Medicare: Medicare Enrolled Practice Location: 974 73rd St, Suite 30, Windsor Heights, IA 50312 Phone: 515-224-4993 Fax: 515-224-1505 |
News Archive
Zinc and folic acid, a pair of dietary supplements long touted as an effective treatment for male infertility, failed to improve pregnancy rates, sperm counts, and sperm potency in a new study conducted at University of Utah Health and other medical centers in conjunction with the National Institutes of Health.
UNYQ, a pioneer in the field of design and 3D printing, announces the launch of its 3D-printed prosthetic leg socket, providing individuals with the perfect product to complement their prosthetic cover.
Thanks to an exciting collaboration between the Queen Elizabeth Hospital Birmingham (QEHB), medical charity Cobalt and Siemens Healthineers, the pioneering Institute of Translational Medicine (ITM) will benefit from an innovative Magnetic Resonance Imaging (MRI) research facility, to be known as the ‘ITM Imaging Centre'.
The Centre for Blood Research (CBR) and the Faculty of Medicine at the University of British Columbia have announced the establishment of the CSL Behring - Canada Research Chair in Endothelial Cell Biology. Over the next five years, the CBR and CSL Behring Canada, the biopharmaceutical company co-funding the chair program, will collaborate on the research and development of new therapies for patients with bleeding and immune system disorders.
VolitionRx Limited, a life sciences company focused on developing diagnostic tests for cancer and other conditions, today announced that it has completed a blinded clinical study demonstrating that its NuQ® blood-based diagnostic platform is able to accurately detect 84% of early, surgically-treatable pancreatic cancers at high 92% specificity.
› Verified 1 days ago